Overview of Financial Results for FY2022 3rd Quarter

CMIC HOLDINGS Co., Ltd.

Jul 29, 2022

Copyright ©2020 CMIC Group - All Rights Reserved

CMIC Group Business

2

CMIC Group Network

25 group companies, 61sites (48 offices, 6 factories, 7 laboratories)

Japan: 12 companies

Overseas: 13 companies

China Korea

USA

HongKong

Vietnam

Thailand

Malaysia

Singapore

Global : 14

（Plants : 2, Lab : 1）

Offices

Plants

Lab

Taiwan

Philippines

Japan : 47

（Plants : 4, Labs : 6）

Australia

Offices

Plants

Labs

3

Change in reportable segment

From FY22, there will be two reportable segments: Pharmaceutical Solutions, which expands PVC models, and Healthcare Solutions, which contributes to the health of individuals through medical institutions and local governments, etc.

4

Focus Activities of Mid-term Management Plan (FY2022-25)

Evolution of healthcare business

Comprehensive support for disease prevention, treatment R&D, and marketing

Contribution to sustainable society through services with high social benefits

5

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

CMIC Holdings Co. Ltd. published this content on 29 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 July 2022 06:54:05 UTC.